Safety assessment of Osilodrostat: The adverse event analysis based on FAERS database by means of disproportionality analysis
Saved in:
| Main Authors: | Lijun Li, Wanchen Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331061/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety assessment of Osilodrostat: The adverse event analysis based on FAERS database by means of disproportionality analysis.
by: Lijun Li, et al.
Published: (2025-01-01) -
Disproportionality analysis of adverse events associated with ipilimumab and nivolumab combination therapy based on FAERS database
by: Xianyu Dai, et al.
Published: (2025-07-01) -
Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
by: Chang-Zhu He, et al.
Published: (2025-03-01) -
Adverse event profiles of EGFR-TKI: network meta-analysis and disproportionality analysis of the FAERS database
by: Jing Shi, et al.
Published: (2025-03-01) -
Tirzepatide safety in type 2 diabetes: a disproportionality analysis of adverse events using the FDA FAERS database
by: Zhenpo Zhang, et al.
Published: (2025-07-01)